VIR compared with LYEL: revenue, margins and what each company keeps, and the suppliers and customers both name

VIRVir Biotechnology, Inc.

Mkt capRevenueRevenue

LYELLyell Immunopharma, Inc.

Mkt capRevenueRevenue

Compare

VIRVir Biotechnology, Inc.

LYELLyell Immunopharma, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

VIR

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±11.7%▼−6.37%×0.55

Q2 FY26±11.6%▼−3.79%×0.33

Q1 FY26±13.9%▼−9.91%×0.71

Feb 24 '26±26.6%▲+27.73%×1.04

LYEL2 of 4 reports

0 of 2at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±28.5%▼−2.79%×0.10

Q2 FY26±35.4%▲+3.52%×0.10

= impliedVIR realized, solidLYEL realized, hatchedOne scale, both sides: full bar = 36%× = |realized| ÷ impliedspan: VIR 254d · LYEL 90dSource: market data

VIRVir Biotechnology, Inc.

12.20▲+10.71%· post 12.30

Mkt cap$2.1BRevenue$239MQ2 FY26Revenue$74MFY24

LYELLyell Immunopharma, Inc.

14.85▼−1.03%· post 14.85

ClosedNov 6 '26

Mkt cap$365.3MRevenue$3,000Q3 FY26Revenue$36,000FY25

Compare

ClosedNov 6 '26

VIRVir Biotechnology, Inc.

LYELLyell Immunopharma, Inc.

12.20▲+10.71%post 12.30

Price

14.85▼−1.03%post 14.85

$2.1B

Mkt cap

$365.3M

Q2 FY26$239M

Revenue

$3,000Q3 FY26

FY24$74M

Revenue

$36,000FY25

VIR12.20▲+10.71%vsLYEL14.85▼−1.03%ClosedNov 6 '26